These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36032111)

  • 1. Persistent but atypical germinal center reaction among 3
    Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Chen Y; Meisel C; Jahrsdörfer B; Ludwig C; Schrezenmeier H; Lino AC; Dörner T
    Front Immunol; 2022; 13():943476. PubMed ID: 36032111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab.
    Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Jahrsdörfer B; Schrezenmeier H; Ludwig C; Sattler A; Kotsch K; Chen Y; Claußnitzer A; Haibel H; Proft F; Guerra G; Durek P; Heinrich F; Ferreira-Gomes M; Burmester GR; Radbruch A; Mashreghi MF; Lino AC; Dörner T
    Arthritis Rheumatol; 2022 Jun; 74(6):934-947. PubMed ID: 34962360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
    Kared H; Jyssum I; Alirezaylavasani A; Egner IM; The Tran T; Tietze L; Lund KP; Tveter AT; Provan SA; Ørbo H; Haavardsholm EA; Vaage JT; Jørgensen K; Syversen SW; Lund-Johansen F; Goll GL; Munthe LA
    Front Immunol; 2024; 15():1296273. PubMed ID: 38455062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
    Mrak D; Tobudic S; Koblischke M; Graninger M; Radner H; Sieghart D; Hofer P; Perkmann T; Haslacher H; Thalhammer R; Winkler S; Blüml S; Stiasny K; Aberle JH; Smolen JS; Heinz LX; Aletaha D; Bonelli M
    Ann Rheum Dis; 2021 Oct; 80(10):1345-1350. PubMed ID: 34285048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.
    Farroni C; Picchianti-Diamanti A; Aiello A; Nicastri E; Laganà B; Agrati C; Castilletti C; Meschi S; Colavita F; Cuzzi G; Casetti R; Grassi G; Petrone L; Vanini V; Salmi A; Repele F; Altera AMG; Maffongelli G; Corpolongo A; Salemi S; Di Rosa R; Nalli G; Sesti G; Vaia F; Puro V; Goletti D
    Front Immunol; 2022; 13():846753. PubMed ID: 35309297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2.
    Thomas Κ; Grigoropoulos I; Alexopoulou P; Karofylakis E; Galani I; Papadopoulou KK; Tsiavou A; Ntourou A; Mavrou E; Qevani I; Katsimbri P; Koutsianas C; Mavrea E; Vassilopoulos D; Pournaras S; Tsiodras S; Boumpas D; Antoniadou A
    Rheumatology (Oxford); 2024 Feb; 63(2):534-541. PubMed ID: 37228039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab.
    Nytrova P; Stastna D; Tesar A; Menkyova I; Posova H; Koprivova H; Mikulova V; Hrdy J; Smela G; Horakova D; Rysankova I; Doleckova K; Tyblova M
    Front Immunol; 2023; 14():1149629. PubMed ID: 37398654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption.
    Gröning R; Dernstedt A; Ahlm C; Normark J; Sundström P; Forsell MNE
    Front Immunol; 2023; 14():1219560. PubMed ID: 37575257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients.
    Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Chen Y; Jahrsdörfer B; Ludwig C; Schrezenmeier H; Lino AC; Dörner T
    Front Immunol; 2022; 13():822885. PubMed ID: 35514962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections.
    Egri N; Calderón H; Martinez R; Vazquez M; Gómez-Caverzaschi V; Pascal M; Araújo O; Juan M; González-Navarro EA; Hernández-Rodríguez J
    Front Immunol; 2023; 14():1146841. PubMed ID: 37180097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germinal centre-driven maturation of B cell response to mRNA vaccination.
    Kim W; Zhou JQ; Horvath SC; Schmitz AJ; Sturtz AJ; Lei T; Liu Z; Kalaidina E; Thapa M; Alsoussi WB; Haile A; Klebert MK; Suessen T; Parra-Rodriguez L; Mudd PA; Whelan SPJ; Middleton WD; Teefey SA; Pusic I; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
    Nature; 2022 Apr; 604(7904):141-145. PubMed ID: 35168246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
    Milo R; Staun-Ram E; Karussis D; Karni A; Hellmann MA; Bar-Haim E; Miller A;
    Front Immunol; 2022; 13():868915. PubMed ID: 35432335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients.
    Fabris M; De Marchi G; Domenis R; Caponnetto F; Guella S; Dal Secco C; Cabas N; De Vita S; Beltrami AP; Curcio F; Quartuccio L
    J Autoimmun; 2022 May; 129():102827. PubMed ID: 35427999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of specific RBD
    Del Pino Molina L; Bravo Gallego LY; Nozal P; Soto-Serrano Y; Martínez-Feito A; Reche-Yebra K; González-Torbay A; Cuesta-Martín de la Cámara R; Gianelli C; Cámara C; González-García J; González-Muñoz M; Rodríguez-Pena R; López Granados E
    Front Immunol; 2023; 14():1136308. PubMed ID: 37215146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials.
    Bisceglia H; Barrier J; Ruiz J; Pagnon A
    J Immunol Methods; 2023 Apr; 515():113457. PubMed ID: 36914088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients.
    Vanni A; Salvati L; Mazzoni A; Lamacchia G; Capone M; Francalanci S; Kiros ST; Cosmi L; Puccini B; Ciceri M; Sordi B; Rossolini GM; Annunziato F; Maggi L; Liotta F
    Front Immunol; 2023; 14():1322594. PubMed ID: 38106404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
    Isnardi CA; Cerda OL; Landi M; Cruces L; Schneeberger EE; Montoro CC; Alfaro MA; Roldán BM; Gómez Vara AB; Giorgis P; Ezquer RA; Crespo Rocha MG; Reyes Gómez CR; de Los Ángeles Correa M; Rosemffet MG; Abarza VC; Pellet SC; Perandones M; Reimundes C; Longueira Y; Turk G; Quiroga MF; Laufer N; Quintana R; de la Vega MC; Kreplak N; Pifano M; Maid P; Pons-Estel GJ; Citera G
    J Rheumatol; 2022 Dec; 49(12):1385-1389. PubMed ID: 36182107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
    Turner JS; O'Halloran JA; Kalaidina E; Kim W; Schmitz AJ; Zhou JQ; Lei T; Thapa M; Chen RE; Case JB; Amanat F; Rauseo AM; Haile A; Xie X; Klebert MK; Suessen T; Middleton WD; Shi PY; Krammer F; Teefey SA; Diamond MS; Presti RM; Ellebedy AH
    Nature; 2021 Aug; 596(7870):109-113. PubMed ID: 34182569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and T Cell Response to SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis.
    Isnardi CA; Landi M; Cruces L; Maid P; Calle Montoro C; Alfaro MA; Roldán BM; Gómez Vara AB; Giorgis P; Ezquer RA; Crespo Rocha MG; Reyes Gómez CR; Correa MÁ; Cerda OL; Rosemffet MG; Carrizo Abarza V; Catalan Pellet S; Perandones M; Reimundes C; Longueira Y; Turk G; Quiroga MF; Laufer N; De La Vega MC; Citera G; Pons-Estel GJ; Schneeberger EE
    Arthritis Care Res (Hoboken); 2024 Jan; 76(1):120-130. PubMed ID: 37605835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases.
    Oliosi E; Flahault A; Charre C; Veyer D; Combier A; Lafont E; Karras A; Mouthon L; Avouac J; Terrier B; Hadjadj J
    Clin Rheumatol; 2023 Sep; 42(9):2485-2490. PubMed ID: 37243801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.